Lonnie Johnson Jr.

Safety

Age: 31
Free Agency: 2026 (UFA)
Accrued Seasons: 7
  • 2026 Salary Cap Charge: $0 (0.00% of cap)
  • 2026 Cash Payout: $0 (0.00% of spending)
  • 2026 Cash to Cap Ratio: 0
  • Contract Value: $1,685,000 ($1,685,000 APY)
  • Fully Guaranteed Money: $175,000
  • Contract Ranking: 63/196 at S

Current Contract

(UFA, signed 2025)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusCap
Number
Cap %
Dead Money & Cap Savings
202530$1,170,000$175,000$340,000$1,645,0000.5%
Total$1,170,000$175,000$340,000$1,645,000

Contract Notes

Lonnie Johnson Jr. signed a one year contract with the Las Vegas Raiders worth $1.685 million contract with $175,000 guaranteed.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.7M
2025
Cash Due$1,685,000
Running Cash$1,685,000
Career Earnings: $9,596,654
Career APY: $1,370,951
Potential Earnings: $9,034,154
Total Guarantees: $10,292,357
Largest Cash Payment: $2,307,112 (2019)
Largest Cap Number: $1,645,000 (2025)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
TitansDraftedExpired20194$5,214,132$1,303,533$3,039,119$1,206,02123.1%$1,206,021
TexansDraftedTraded20194$5,214,132$1,303,533$3,039,119$4,008,13376.9%$1,336,044
ChiefsDraftedClaimed20194$5,214,132$1,303,533$3,039,119$00.0%$0
SaintsUFATerminated20231$1,232,500$1,232,500$0$1,232,500100.0%$1,232,500
TexansUFATerminated20241$2,000,000$2,000,000$1,000,000$00.0%$0
PanthersPracticeRenegotiated20241$424,600$424,600$0$00.0%$0
PanthersPracticeElevated20241$383,400$383,400$0$00.0%$0
PanthersSFAExpired20241$1,125,000$1,125,000$0$1,062,50094.4%$1,062,500
RaidersUFAActive20251$1,685,000$1,685,000$175,000$1,525,00090.5%$1,525,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Titans1$1,206,021$1,206,021$1,206,0210.0%$00.0%
Texans3$4,508,133$1,502,711$3,555,1050.0%$1,453,0280.0%
Chiefs0$0$0$00.0%$00.0%
Saints1$1,232,500$1,232,500$1,092,5000.0%$00.0%
Panthers1$1,125,000$1,125,000$1,062,5000.0%$54,7220.0%
Raiders1$1,525,000$1,525,000$1,645,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2019Texans$495,000$453,028$0$0$495,000$948,0280.4%$2,307,112
2020Texans$732,007$453,028$0$0$732,007$1,185,0350.5%$732,007
2021Texans$969,014$453,028$0$0$0$1,422,0420.7%$969,014
2022Titans$1,206,021$0$0$0$0$1,206,0210.6%$1,206,021
2023Saints$1,080,000$0$152,500$0$0$1,092,5000.5%$1,232,500
2024Panthers$1,125,000$0$0$0$0$1,062,5000.4%$1,062,500
2025Raiders$1,170,000$175,000$0$340,000$0$1,645,0000.5%$1,525,000
Total$6,777,042$1,534,084$152,500$340,000$1,227,007$8,561,126$9,034,154
Dead Money History
TeamYearCap ChargeCash Paid
Texans2022$453,028$0
Texans2024$1,000,000$500,000
Panthers2024$54,722$62,500
Total$1,507,750$562,500

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
DefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
201914249.6%23.2%34700007000000
202016063.4%41.7%502000130000000
202113146.2%25.0%341700106300000
202212114.1%40.6%7200000000000
202312511.0%50.7%3100002100000
20241322.9%55.6%0100000000000
20259028.5%16.0%141100002000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$1,862,000$1,685,000
Injury Adjusted$1,862,000$1,685,000
test
OTC Valuation $2.4M $4.9M $7.3M $9.8M $12.2M APY $4.2M $8.4M $12.6M $16.7M $20.9M $5,549,000 $4,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.